Robert Randall (1948–2001) — The Man the Federal Government Grew Marijuana For

Glaucoma and the accidental discovery

Randall was diagnosed with open-angle glaucoma in his mid-twenties. The condition causes progressive damage to the optic nerve through elevated intraocular pressure (IOP), and without effective treatment it leads to blindness. The conventional treatments available in the early 1970s were partially effective but insufficient to prevent Randall's progressive vision loss.

Randall discovered by accident that smoking cannabis lowered his intraocular pressure. The observation was subjective at first — he noticed that his vision improved after using marijuana. He sought medical confirmation from Dr. Robert Hepler at UCLA, who had published research demonstrating that cannabis reduced IOP. Hepler's clinical measurements confirmed what Randall had observed: cannabis was lowering his eye pressure more effectively than the available conventional treatments.

Arrest and the medical necessity defense

Randall's arrest was the kind of case that changes law — not because the facts were complicated, but because they were simple. A man was going blind. Cannabis demonstrably lowered his eye pressure. The government was prosecuting him for growing the plant that preserved his sight. The moral equation was stark.

Attorney John Karr took Randall's case and mounted a medical necessity defense — arguing that Randall's use of cannabis was medically necessary to prevent blindness, and that the necessity outweighed the illegality of the drug.

United States v. Randall did not legalize medical cannabis. It established that under specific circumstances — a serious medical condition, demonstrated therapeutic benefit, no adequate legal alternative — medical necessity could serve as a defense against cannabis prosecution. The ruling was narrow, but its principle was revolutionary.

The Compassionate IND

Randall did not stop at winning his court case. He petitioned the federal government for a legal supply of cannabis. The logic was inescapable: a federal court had ruled that his use of cannabis was medically necessary. The government could not simultaneously acknowledge that necessity and deny him access to the drug.

The Food and Drug Administration created a Compassionate Investigational New Drug (IND) program to supply Randall with cannabis. The marijuana came in the form of pre-rolled cigarettes produced at the University of Mississippi — the only federally licensed cannabis cultivation facility in the United States. Randall became the first American to receive legal cannabis from the federal government since the Marihuana Tax Act of 1937.

Alliance for Cannabis Therapeutics

Randall and his wife, Alice O'Leary, co-founded the Alliance for Cannabis Therapeutics (ACT) to advocate for other patients' access to the Compassionate IND program. Their work expanded the program to include additional patients with serious medical conditions — cancer, AIDS, multiple sclerosis, and other conditions where cannabis provided demonstrated therapeutic benefit.

The program closes

The closure of the Compassionate IND to new applicants in 1992 is one of the most revealing episodes in American drug policy. The government shut down a medical program because too many sick people wanted access to it. The contradiction between Schedule I classification — "no currently accepted medical use" — and a federal program supplying cannabis for medical use was becoming politically untenable. Rather than resolve the contradiction by rescheduling cannabis, the government resolved it by denying access to new patients.

Death and legacy

Randall wrote Marijuana Rx: The Patients' Fight for Medicinal Pot in 1998, documenting his legal battle and the Compassionate IND program.

The fact that federal cannabis patients still exist — still receiving their monthly tins of government-grown marijuana — is perhaps the most pointed contradiction in American drug policy. The government's own program demonstrates what its own scheduling denies.